Sanofi, Formation Bio, and OpenAI collaborate to create AI-powered drug development software.

Sanofi, Formation Bio and OpenAI announced a first-in-class AI collaboration to build AI-powered software, aiming to accelerate drug development and bring new medicines to patients more efficiently. The companies will combine data, software and tuned models to create custom solutions across the drug development lifecycle. Sanofi will leverage this partnership to provide access to proprietary data, as it aims to become the first biopharma company powered by AI at scale.

May 21, 2024
11 Articles